INS and overnutrition: On the other hand, as reviewed within, the learning of this pharmacology over the last three decades suggests that the TZD pharmacology uncouples the adverse effects of overnutrition from the dysfunction that would otherwise occur involving insulin target tissues, the pancreatic islets, and the immune system and that these effects can favorably impact interrelated chronic diseases of metabolism.